Restoration of Mutant K-Ras Repressed Mir-199B Inhibits K-Ras Mutant Non-Small Cell Lung Cancer Progression

Hua Jin,Yoonjeong Jang,Nian Cheng,Qing Li,Peng-Fei Cui,Zhi-Wei Zhou,Hu-Lin Jiang,Myung-Haing Cho,Kenneth D. Westover,Qun-You Tan,Cheng-Xiong Xu

DOI: https://doi.org/10.1186/s13046-019-1170-7

IF: 12.658

2019-01-01

Journal of Experimental & Clinical Cancer Research

Abstract:BACKGROUND:miRNAs play crucial role in the progression of K-Ras-mutated nonsmall cell lung cancer (NSCLC). However, most studies have focused on miRNAs that target K-Ras. Here, we investigated miRNAs regulated by mutant K-Ras and their functions.METHODS:miRNAs regulated by mutant K-Ras were screened using miRNA arrays. miR-199b expression levels were measured by qRT-PCR. The protein expression levels were measured using Western blot and immunohistochemistry. The effects of miR-199b on NSCLC were examined both in vitro and in vivo by overexpressing or inhibiting miR-199b. DNA methylation was measured by bisulfite sequencing.RESULTS:An inverse correlation was observed between K-Ras mutation status and miR-199b levels in NSCLC specimens and cell lines. The inhibition of miR-199b stimulated NSCLC growth and metastasis, while restoration of miR-199b suppressed K-Ras mutation-driven lung tumorigenesis as well as K-Ras-mutated NSCLC growth and metastasis. miR-199b inactivated ERK and Akt pathways by targeting K-Ras, KSR2, PIK3R1, Akt1, and Rheb1. Furthermore, we determined that mutant K-Ras inhibits miR-199b expression by increasing miR-199b promoter methylation.CONCLUSION:Our findings suggest that mutant K-Ras plays an oncogenic role through downregulating miR-199b in NSCLC and that overexpression of miR-199b is a novel strategy for the treatment of K-Ras-mutated NSCLC.